IMG-025

N/A

Report date: 2023/05/22 10:17:37
NME

Base Information

Drug NameIMG-025
Drug Alias NameIMG025
ClassificationDiagnostic agent (In vivo) > Contrast agent
Mechanisms of ActionMannan-binding lectin serine protease 2 modulators
TargetsMannan-binding lectin serine protease 2
Therapy Area/IndicationsGlomerulonephritis, IGAInfections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesIkena Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesIkena Oncology Inc
Inactive CompaniesN/A
Active IndicationsGlomerulonephritis, IGAInfections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A